Filtered By:
Source: Journal of Stroke and Cerebrovascular Diseases
Drug: Modafinil
Countries: Australia Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Exploring the Economic Benefits of Modafinil for Post-Stroke Fatigue in Australia: A Cost-Effectiveness Evaluation
Post-stroke fatigue remains a substantial ‘silent disability’, affecting up to three-quarters of stroke survivors,1,2 and rating among the worst symptoms experienced by nearly half of stroke survivors.3 On the spectrum of stroke complications, fatigue receives considerably less attention than more visible physical disabilities,4 despite fatigue adversely affecting clinical outcomes and quality of life, and being an independent predictor of institutionalisation, dependence in activities of daily living, poorer functional outcomes, and death.
Source: Journal of Stroke and Cerebrovascular Diseases - October 14, 2020 Category: Neurology Authors: Beata Bajorek, Lan Gao, Tom Lillicrap, Andrew Bivard, Carlos Garcia-Esperon, Mark Parsons, Neil Spratt, Elizabeth Holliday, Chris Levi Source Type: research
